These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [What is assured in drug prevention of thrombosis with special reference to low molecular weight heparin?]. Daiss W, Dölle W. Internist (Berl); 1989 Dec; 30(12):784-9. PubMed ID: 2559898 [No Abstract] [Full Text] [Related]
8. [Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity]. Kock HJ, Schmit-Neuerburg KP, Hanke J, Hakmann A, Althoff M, Rudofski G. Vasa Suppl; 1992 Dec; 35():105-6. PubMed ID: 1336215 [No Abstract] [Full Text] [Related]
9. Can the bleeding potential of low molecular weight heparins be assessed and minimized in postsurgery prophylaxis? Toulemonde F. Semin Thromb Hemost; 1991 Oct; 17(4):351-5. PubMed ID: 1666455 [No Abstract] [Full Text] [Related]
16. ["How must deep leg venous thrombosis be diagnosed and treated?"]. Bruhn HD. Dtsch Med Wochenschr; 2003 Aug 15; 128(33):1730-1. PubMed ID: 12920673 [No Abstract] [Full Text] [Related]
17. [When long-term marcumar administration is needed. Low-molecular-weight heparin bridges the surgery gap]. MMW Fortschr Med; 2001 Feb 22; 143(8):52. PubMed ID: 11265545 [No Abstract] [Full Text] [Related]